Cash Flow Statement

Amortizatization of Intangibles Amortizatization of Intangibles Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Depreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other financing activities Other financing activities Share-based Compensation Share-based Compensation Shares Issued

Daily Values

Others

Ratios

Rallybio (RLYB) Other financing activities (2023 - 2024)

Rallybio's Other financing activities history spans 2 years, with the latest figure at $11000.0 for Q3 2024.

On a quarterly basis, Other financing activities changed N/A to $11000.0 in Q3 2024 year-over-year; TTM through Dec 2025 was $11000.0, a 95.9% decrease, with the full-year FY2024 number at $268000.0, up 92.81% from a year prior.
Other financing activities hit $11000.0 in Q3 2024 for Rallybio, down from $257000.0 in the prior quarter.
Over the last five years, Other financing activities for RLYB hit a ceiling of $257000.0 in Q2 2024 and a floor of -$1000.0 in Q2 2023.